MedPath
NMPA Approval

Dobutamine Hydrochloride Injection

国药准字H20244807

September 3, 2024

Drug Information

盐酸多巴酚丁胺注射液

注射剂

5ml:100mg(按C₁₈H₂₃NO₃计)

化学药品

September 3, 2024

Company Information

Applicant Company

南京市栖霞区仙林街道纬地路9号江苏生命科技园D6栋903、905、907室

Manufacturing Company

东台市纬八路15号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸多巴酚丁胺注射液 - NMPA 批准文号 | MedPath